Presentations at conferences

April 2019

  • Burr HA, Pilote L, Cheema A, Dufresne L, Chen HY, Thanassoulis G, Engert JC. Identifying the Genetic Determinants of Spontaneous Coronary Artery Dissection with Whole Exome Sequencing. 2019 Department of Medicine Research Symposium. Montreal, QC. 24 April 2019. Poster.
  • Malhamé I, Destiné R, Coriolan B, Excellent MC, Loth WS, Von Oettingen J, Pilote L, Israel K; the DYAMAN investigators group. Prevalence and outcomes of hypertensive disorders of pregnancy and gestational diabetes mellitus in Haiti: the DYAMAN study. Abstract Accepted – Poster Presentation. Unite for Sight 16th Annual Global Health & Innovation Conference, Yale University, New Haven, Conneticut, April 15, 2019.
  • Wali A, Raparelli V, Pilote L. Blood pRessure And Vascular hEalth around menopause (BRAVE). Abstract Accepted – Poster Presentation. Quality of Care and Outcomes Research 2019 Scientific Sessions Conference, Arlington, Virigina, April 5-6, 2019. Recipient of the 2019 Paul Dudly White International Scholar Award.

 

May 2019

  • Organization for the Study of Sex Differences/International Society of Gender Medicine 2nd Joint Meeting (5th-8th of May 2019, USA)
  • Kautzky-Willer A. ÖDG-Frühjahrstagung 2019 (24th-25th of May 2019, Austria)
  • Kautzky-Willer A. Geschlechterunterschiede bei Frauen und Männern mit Diabetes – Was können wir im Alltag umsetzen?. Diabetes Kongress 2019 - Jahrestagung der Deutschen Diabetes Gesellschaft; Berlin (Germany); 31st of May 2019.
  • Kautzky-Willer A. Wozu Wissenschaft. Wiener Vorlesung; Vienna (Austria); 28.05.2019.
  • Kautzky-Willer A. Gravidität und Gestationsdiabetes. 35. ÖDG-Frühjahrstagung 2019; Vienna (Austria); 25th of May 2019.
  • Kautzky-Willer A. Sex and Gender Matter in Diabesity: From Pathophysiology to Prevention and Personalized Therapy. Organization for the Study of Sex Differences/International Society of Gender Medicine 2nd Joint Meeting; Washington, DC (USA); 6th of May 2019.
  • Burr HA, Pilote L, Cheema A, Dufresne L, Chen HY, Thanassoulis G, Engert JC. Identifying the Genetic Determinants of Spontaneous Coronary Artery Dissection with Whole Exome Sequencing. 2019 McGill University Health Centre Cardiovascular Research Day. Montreal, QC. 29 May 2019. Poster.
  • Elharram M, Pilote L. Anticoagulant use and the risk of thromboembolism and cleeding in post-operative atrial fibrillation following non-cardiac surgery. Abstract Accepted Oral Presentation – 2019 McGill Cardiovascular Research Day, Montreal, Quebec, May 29, 2019.
  • Samuel M, Pilote L. Catheter ablation is associated with reduced all-cause mortality in a real-world cohort of patients with atrial fibrillation and heart failure. Abstract Accepted Oral Presentation – 2019 McGill Cardiovascular Research Day, Montreal, Quebec, May 29, 2019.
  • Khan S, Pilote L. Investigating knowledge and perceptions of male and female users of health products: cosmetics, natural health products and non-prescription drugs. Poster Presentation – 2019 Centre for Outcomes Research & Evaluation Research Day, Montreal, Quebec, May 14, 2019.
  • Gerendas BS, Neschi M, Michl M, Kostiantyn L, Deak GG, Winhofer Y, Kautzky-Willer A, Abramoff MD, Schmidt-Erfurth U. FDA-authorized autonomous AI for diabetic retinopathy screening in clinical routine. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO); 28. April - 2. May 2019; Vancouver (Canada). Invest Ophthalmol Vis Sci. 2019;60(9):4776.
  • EVBM oral presentation (Karolina Kublickiene)

 

June 2019

  • ACT on gender EU consortium meeting for training CoPs for implementation of gender dimension (Karolina Kublickiene responsible for workshop)
  • Samuel M, Abrahamowicz M, Joza J, Essebag V, Pilote L. Population-level referral patterns for catheter ablation in patients with atrial fibrillation and comorbid heart failure. Abstract Accepted Poster Presentation – 2019 Society for Epidemiologic Research Annual Meeting, Minneapolis, Minnesota, June 18-21 2019.

 

July 2019

  • Burr HA, Pilote L, Cheema A, Dufresne L, Chen HY, Thanassoulis G*, Engert JC. Identifying the Genetic Determinants of Spontaneous Coronary Artery Dissection: An Analysis of Whole Genome Sequences. Poster presentation. ASHG 2019, Boston, MA, United States. May 14-16, 2019. Abstract originally published, 19 Jul 2019, Arteriosclerosis, Thrombosis, and Vascular Biology. 2019;39:A199

 

August 2019

  • Samuel M, Abrahamowicz M, Joza J, Beauchamp M, Essebag V, Pilote L. Catheter ablation is associated with reduced all-cause mortality in a real-world cohort of patients with atrial fibrillation and heart failure. Abstract accepted poster presentation- 2019 European Society of Cardiology (ESC) Congress, Paris, France, August 31-September 3 2019.
  • Parry M, Clarke H, Bjoernnes AK, Cafazzo J, Cooper L, Dhukai A, Harvey P. Katz J, Lalloo C, Leegaard M, Legare F, McFetridge-Durdle J, McGillion M, Norris C, Patterson R, Pilote L, Pink L, Price J, Stinson J, Victor JC, Watt-Watson J, Auld C, Faubert C, Park D, Park M, Rickard B, Spiteri DeBonis V. Development and usability testing of HEARTPA♀N: Protocol for an intergrated smartphone and web-based intervention for women with cardiac pain. Abstract Submitted – European Society of Cardiology, Paris, France, August 31-September 4, 2019.
  • Malhamé I, Destiné R, Pilote L. Evaluating the performance of a screening questionnaire to detect left ventricular systolic dysfunction among peripartum women in Haiti. Abstract Accepted – European Society of Cardiology, Paris, France, August 31-September 4, 2019.

 

September 2019

  • 9th Congress of the International Society of Gender Medicine (12th-13th of September 2019, Austria) (Univ.-Prof.in Dr.in Alexandra Kautzky-Willer)
  • Zoobiquity Event at Karolinska Institutet. Leading physicians, veterinarians, clinical and experimental researchers gathered at Biomedicum for the Zoobiquity event in September, 2019. It offered a collaborative and interactive atmosphere for all attendees to immerse in bio-inspired research focused on two challenges in women’s health: Cardiovascular Disease and Reproductive health, including fertility Preservation. (Organizer Karolina Kublickiene)
  • Presentation of the GFWD protocol at the International Society of Gender Medicine meeting, Austria (Valeria Raparelli)
  • Kautzky-Willer A. Sex and Gender Differences in Antihyperglycemic Treatment. 9th Congress of the International Society of Gender Medicine; Vienna (Austria); 13th of September 2019.
  • Samuel M, Abrahamowicz M, Joza J, Beauchamp M, Essebag V, Pilote L. Catheter Ablation is associated with reduced all-cause mortality in a real-world cohort of patients with atrial fibrillation and heart failure. Poster presentation. Canadian Heart Rhythm Society, Montreal, QC, September 2019.
  • Samuel M, Abrahamowicz M, Joza J, Pilote L, Essebag V. Population-level evaluation of major adverse events after catheter ablation in patients with atrial fibrillation and comorbid heart failure. Pilote L Submitted Poster presentation. Latin American Heart Rhythm Society, Guadalajara, Mexico, September 2019.
  • Harreiter J, Simmons D, Desoye G, Corcoy R, Devlieger R, Mathiesen ER, Damm P, Jensen DM, Dunne F, Lapolla A, Dalfra MG, Hill D, van Poppel MNM, Kautzky-Willer A, Grp DCI. Increased free fatty acids, ketone bodies and fasting glucose after nutritional lifestyle intervention in obese pregnant women: a secondary analysis of the DALI study. 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); 16.-20. September 2019; Barcelona (Spain). Diabetologia. 2019;62(SUPPL 1):S445-S6.
  • Hufgard-Leitner M, Leitner K, Fragner L, Brenner M, Sun X, Weckwerth W, Kautzky-Willer A. Metabolomic Profiles Differentiate Men and Women in Accordance With Metabolic Disease. 9th Congress of the International Society of Gender Medicine; 12.-13. September 2019; Vienna (Austria). Gend Genome. 2019;3:10.
  • Kautzky-Willer A. Sex and Gender Differences in Antihyperglycemic Treatment. 9th Congress of the International Society of Gender Medicine; 12.-13. September 2019; Vienna (Austria). Gend Genome. 2019;3:21-2.
  • Schernthaner-Reiter M-H, Baumgartner-Parzer S, Egarter HC, Kirchheiner K, Krebs M, Kautzky-Willer A, Luger A, Bayerle-Eder M. Sexual Function, Gender Role, and Sexual Preference in Females with Classical Versus Nonclassical Congenital Adrenal Hyperplasia. 9th Congress of the International Society of Gender Medicine; 12.-13. September 2019; Vienna (Austria). Gend Genome. 2019;3:23.
  • Kosi Trebotic L, Deischinger C, Thomas A, Just-Kukurova I, Trattnig S, Kaufmann U, Kautzky-Willer A. Cardiometabolic Effects of Cross Sex Hormone Therapy in Transgender Patients. 9th Congress of the International Society of Gender Medicine; 12.-13. September 2019; Vienna (Austria). Gend Genome. 2019;3:24.
  • Raparelli V, Trinidad Herrero M, O. Johnson E, Kautzky-Willer A, Kublickiene K, Norris CM, Pilote L. The Going-FWD (Gender Outcomes International Group: to Further Well-being Development) Project". 9th Congress of the International Society of Gender Medicine; 12.-13. September 2019; Vienna Austria. Gend Genome. 2019;3:29.
  • Leutner M, Matzhold C, Bellach L, Deischinger C, Harreiter J, Thurner S, Klimek P, Kautzky-Willer A. The Diagnosis of Osteoporosis in Statin-Treated Women and Men is Dose-Dependent. 9th Congress of the International Society of Gender Medicine; 12.-13. September 2019; Vienna (Austria). Gend Genome. 2019;3:30.
  • Harreiter J, Schneeweiss U, Klein W, Moser H, Kautzky-Willer A. Sex and Gender Specific Aspects in the Development of Post Stroke Depression and ITS Effects on Neuro-Rehabilitation Success. 9th Congress of the International Society of Gender Medicine; 12.-13. September 2019; Vienna (Austria). Gend Genome. 2019;3:33-4.
  • Deischinger C, Dervic E, Kosi-Trebotic L, Kautzky A, Klimek P, Kautzky-Willer A. Gender Gap in Diagnosis of Depression More Prevalent in Type 2 Diabetes Mellitus Patients than Non-Diabetics in Austria. 9th Congress of the International Society of Gender Medicine. 2019;3:34-5.
  • Ofenheimer A, Breyer-Kohansal R, Altziebler JV, Hartl S, Burghuber OC, Schrott A, Urban M, Purin D, Heinzle C, Drexel H, Franssen FME, Wouters EFM, Harreiter J, Kautzky-Willer A, Breyer MK. Differences in prediabetes and diabetes associated co-morbidities between men and women. 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); 16.-20. September 2019; Barcelona (Spain). Diabetologia. 2019;62(SUPPL 1):S148-S9.
  • Nadasdi A, Gal V, Rosta K, Harreiter J, Kautzky-Willer A, Somogyi A, Firneisz G. Negative correlation between the early glucagon response and intrahepatic content of lipid (IHCL) in individuals with PNPLA3 rs738409 CCgenotype. 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); 16.-20. September 2019; Barcelona (Spain). Diabetologia. 2019;62(SUPPL 1):S523.
  • Kautzky-Willer A, Harreiter J, Berger-Kulemann V, Quasthoff R, Weber M, Hachemian N, Schwartz E, Kasprian G, Prayer D. 'Supersize me' - Is a diagnosis of gestational diabetes associated with foetal brain volume? 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); 16.-20. September 2019; Barcelona (Spain). Diabetologia. 2019;62(SUPPL 1):S81.
  • Parry M, Clarke H, Bjoernnes AK, Cafazzo J, Cooper L, Dhukai A, Harvey P. Katz J, Lalloo C, Leegaard M, Legare F, McFetridge-Durdle J, McGillion M, Norris C, Patterson R, Pilote L, Pink L, Price J, Stinson J, Victor JC, Watt-Watson J, Auld C, Faubert C, Park D, Park M, Rickard B, Spiteri DeBonis V. Development and usability testing of HEARTPA♀N: Protocol for an intergrated smartphone and web-based intervention for women with cardiac pain. Abstract Submitted – European Society of Cardiology, Paris, France, August 31-September 4, 2019.

 

October 2019

  • Kautzky-Willer A. Wrap-Up ACC/ADA/DDG/EASD 2019 (24th of October 2019, Austria)
  • Kautzky-Willer A. Update Diabetes, Schwangerschaft und die Jahre danach. Wrap-Up ACC/ADA/DDG/EASD 2019; Vienna (Austria); 24th of October 2019.
  • Burr HA, Pilote L, Cheema A, Dufresne L, Chen HY, Thanassoulis G, Engert JC. Identifying the Genetic Determinants of Spontaneous Coronary Artery Dissection: An Analysis of Whole Genome Sequences. The American Society of Human Genetics 2019 Annual Meeting. Houston, TX. 16 Oct 2019. Poster.
  • Kautzky-Willer A. Gender Medicine as a door opener to individualized, data based medicine. EWMD International Conference 2019: „Will my doctor be an app?“ The future of gendered, individualized, data-based medicine and health business.; Vienna (Austria); 12th of October 2019.

 

November 2019

  • Kautzky-Willer A. ÖDG-Jahrestagung 2019 (21st-23rd of November 2019)
  • Poster presentation at the Clinical Research Symposium on High Value Medical Care McGill University (Uri)
  • Kautzky-Willer A. GDM Workshop. Medical University of Vienna Center of Excellence in Diabetes & its Complications for the MEA Region; Vienna (Austria); 30th of November 2019.
  • Kautzky-Willer A. Gestational Diabetes Mellitus & Diabetes and Pregnancy - Challenges and Progress. Medical University of Vienna Center of Excellence in Diabetes & its Complications for the MEA Region; Vienna (Austria); 30th of November 2019.
  • Kautzky-Willer A. Morbid Obesity across the world and its consequences. Medical University of Vienna Center of Excellence in Diabetes & its Complications for the MEA Region; Vienna (Austria); 29th of November 2019.
  • Kautzky-Willer A, Krebs M, Stingl H. Gesundheitsbezogene Lebensqualität bei Typ 2 Diabetikern unter Therapie mit Insulin oder oralen Antidiabetika. 47. ÖDG-Jahrestagung 2019; Salzburg (Austria); 22nd of November 2019.
  • Kautzky-Willer A, Krebs M, Stingl H. Messung der Lebensqualität bei Patienten mit Diabetes mellitus Typ 1 und Typ 2 in Abhängigkeit vom HbA1c. 47. ÖDG-Jahrestagung 2019; Salzburg (Austria); 22nd of November 2019.
  • Kautzky-Willer A. Lipidtherapie heute: was sagen die neuen Guidelines. 47. ÖDG-Jahrestagung 2019; Salzburg (Austria); 21st of November 2019.
  • Kautzky-Willer A. Was ist Gender-Medizin und wie kann sie im klinischen Alltag umgesetzt werden?. Kick-off Symposium «Chancen und Perspektiven der Gendermedizin»; Zürich (Switzerland); 15th of November 2019.
  • Kautzky-Willer A. Gendermedizin – Werden Frauen und Männer anders krank?. Symposium Familiäre Hypercholesterinämie (FH) und weitere genetische Lipidstoffwechselstörungen; Vienna (Austria); 12th of November 2019.

 

December 2019

  • Kautzky-Willer A. Adipositas aus internistischer Sicht. 30. Menopausekongress 2019; Vienna (Austria); 6th of December 2019.

 

January 2020

  • Presentation at the COGS (Canadian Organization for Gender and Sex Research) (Louise Pilote)
  • Kautzky-Willer A. Ist es als Diabetiker besser, eine Frau zu sein?. 12. Hauptstadt-Symposium Diabetes 2020; Berlin (Germany); 18th of January 2020.

 

February 2020

  • Patient partner engagement and training sessions (Monica Parry)
  • Burr HA, Pilote L, Cheema A, Dufresne L, Chen HY, Thanassoulis G*, Engert JC. Identifying the Genetic Determinants of Spontaneous Coronary Artery Dissection: An Analysis of Whole Genome Sequences. Poster presentation. Rare disease Research Day, RI-MUHC Consortium for Rare Disease Research (CRDR) Feb 28, 2020. Montreal, Quebec.

 

March 2020

  • Kautzky-Willer A. Gestations DM, Gender Aspekte. 53. Wissenschaftlichen Fortbildung in Schladming 2020: Diabetes Mellitus - Metabolisches Syndrom; Schladming (Austria); 8th of March 2020.

 

April 2020

  • Raparelli V, Norris CM, Herrero MT, Johnson EO, Kautzky-Willer A, Kublickiene K, Pilote L, on behalf of the GOING-FWD Consortium. The GOING-FWD (Gender Outcomes INternational Group: to Further Well-being Development) Project. Poster presentation. 2020 Canadian Women’s Heart Health Summit. Ottawa, Ontario, Canada, April 2 and 3, 2020. (Conference Cancelled due to COVID-19)
  • Tucci C, Tosti G, Basili S, Herrero Ezquerro MT, Johnson EO, Kautzky-Willer A, Norris CM, Pilote L, Kublickiene K, Raparelli V, on behalf of GOING FWD Consortium Gender-related Factors and Cost-sensitive Outcomes in Adults with Chronic Kidney Disease: a Systematic Review. Poster presentation. 2020 Canadian Women’s Heart Health Summit. Ottawa, Ontario, Canada, April 2 and 3, 2020. (Conference Cancelled due to COVID-19)
  • Tosti G, Tucci C, Basili S, Herrero Ezquerro MT, Johnson EO, Kautzky-Willer A, Norris CM, Pilote L, Kublickiene K, Raparelli V, on behalf of GOING FWD Consortium Gender-related Factors and Patient-related Outcome Measures/Patient-reported Experience Measures in Adults with Chronic Kidney Disease: a Systematic Review. Poster presentation. 2020 Canadian Women’s Heart Health Summit. Ottawa, Ontario, Canada, April 2 and 3, 2020. (Conference Cancelled due to COVID-19)
  • Tadiri C, Quaiattini A, Norris C, Raparelli V, Pilote L on behalf of the GOING-FWD Consortium. Applying a Gender-Based Approach to Systematic Reviews: Inconsistencies in Definitions and Indexing. Poster presentation. 2020 Canadian Women’s Heart Health Summit. Ottawa, Ontario, Canada, April 2 and 3, 2020. (Conference Cancelled due to COVID-19)
  • Bender U, Raparelli V, Pilote L on behalf of the GOING-FWD Consortium. Do Sex Hormones Mediate the Effect of Gender on Acute Coronary Syndrome Outcomes? Poster presentation. 2020 Canadian Women’s Heart Health Summit. Ottawa, Ontario, Canada, April 2 and 3, 2020. (Conference Cancelled due to COVID-19)

 

May 2020

  • Raparelli V, Dreyer R, Pilote L. Impact of Sex, Gender and Healthcare System on the Quality of Care in Young Adults With Acute Myocardial Infarction. Poster presentation. AHA Quality of Care and Outcomes Research Scientific Sessions. Reston, VA. May 15-16, 2020. (Receipient of the Paul Dudley White International Scholar Award, Authors with the Highest Ranked Abstract from Italy (Dr. Raparelli) Quality of Care and Outcomes Research Scientific Sessions 2020)
  • Raparelli V, Norris CM, Herrero Ezquerro MT, Johnson EO, Kautzky-Willer A, Kublickiene K, Pilote L, on behalf of the GOING-FWD Consortium. The Gender Outcomes INternational Group: to Further Well-being Development (GOING-FWD). Methodology on Inclusion of Gender Factors in Observational Studies of Chronic Diseases. Poster presentation. OSSD 2020 (The Organization for the Study of Sex Differences). Marina Del Ray, California, USA. May 4-7, 2020 (Conference Cancelled due to COVID-19)
  • Tadiri C*, Gisinger T *, Bender U, Deischinger C, Raparelli V, Dreyer RP, Norris CM, Klimek P, Kautzky-Willer A, Pilote L, on behalf of the GOING-FWD Consortium (*equally contributing co-first authors). Sex, Gender and Country: What We Have Learned on the Harmonization of Databases from International Observational Studies. Poster presentation. OSSD 2020 (The Organization for the Study of Sex Differences). Marina Del Ray, California, USA. May 4-7, 2020 (Conference Cancelled due to COVID-19)
  • Bender U, Tosti G, Tucci C, Tadiri C, Herrero Ezquerro MT, Johnson EO, Kautzky-Willer A, Norris CM, Pilote L, Kublickiene K, Raparelli V, on behalf of the GOING-FWD Consortium. Gender-related Factors and Patient-related Outcome Measures/Patient-reported Experience Measures in Adults with Chronic Kidney Disease: a Systematic Review. Poster presentation. OSSD 2020 (The Organization for the Study of Sex Differences). Marina Del Ray, California, USA. May 4-7, 2020 (Conference Cancelled due to COVID-19)

 

August 2020

  • Amaral de Ávila Machado M, Moura CS, Chan K, Curtis JR, Hudson M, Abrahamowicz M, Colmegna I, Jamal R, Pilote L, Chan AW, Bernatski S. Pre-existing autoimmune disease and immune-related adverse events with checkpoint inhibitors in melanoma. Poster presentation. 41st Annual Conference of the International Society for Clinical Biostatistics (ISCB), Krakow, Poland August 23-27, 2020.
  • Amaral de Ávila Machado M, Moura CS, Chan K, Curtis JR, Hudson M, Abrahamowicz M, Colmegna I, Jamal R, Pilote L, Chan AW, Bernatski S. Pre-Existing Autoimmune Disease And Immune-Related Adverse Events (irAE) With Checkpoint Inhibitors In Metastatic Melanoma. Poster presentation. 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE). Berlin, Germany. August 26-30, 2020.

 

September 2020

  • Tadiri CP, Gisinger T, Kautzky -Willer A, Kublickiene K, Herrero MT, Raparelli V, Pilote L, Norris CM; GOING-FWD Consortium. The influence of sex and gender domains on COVID-19 cases and mortality. CMAJ. 2020 Sep 8;192(36):E1041-E1045. doi: 10.1503/cmaj.200971. PMID: 32900766. (https://www.cmaj.ca/content/192/36/E1041).

Gender-Net Plus interviews of Co-Pis (Louise Pilote, Colleen Norris, Valeria Raparelli)

  • (YouTube: https://www.youtube.com/channel/UC9EyrfyABidEitDdP09pkxQ
  • CIHR IGH Meet the methods series: "factsheet" about methods for incorporating gender into clinical research loiuse colleen valeira
  • Kautzky-Willer A. PANEL 5 – Lifestyle changes that can have a positive impact on brain and mental health–a sex and gender perspective: sex differences in lifestyle risk factors, including obesity and diabetes - an overview. International Forum on Women’s Brain and Mental Health; Virtual Meeting; 20th of September 2020.
  • Raparelli V, Pilote L, Behlouli H, Dziura J, Bueno H, D'onofrio G, Krumholz HM, Dreyer RP. The impact of sex, gender and healthcare system on quality of care among young adults with acute myocardial infarction. Poster presentation. European Society of Cardiology (ESC) Congress 2020, Virtual congress. August 29th to September 1st, 2020.

October 2020

  • Tadiri CP, Raparelli V, Abrahamowicz M, Kautzky -Willer A, Kublickiene K, Herrero MT, Norris CM, Pilote L. Methods for prospectively incorporating gender into health sciences research. Journal of Clinical Epidemiology. Published online, Sept 23, 2020. doi: https://doi.org/10.1016/j.jclinepi.2020.08.018.
  • Raparelli V, Norris CM, Bender U, Herrero MT, Kautzky -Willer A, Kublickiene K, El Emam K, Pilote L and the GOING‑FWD Collaborators. The Gender Outcomes INternational Group: to Further Well-being Development (GOING-FWD) Methodology on Identification and Inclusion of Gender Factors in Retrospective Cohort Studies. (Submitted)
  • Merged with the other EU events on gender dimensions, GOING-FWD is featured in the “Educational course" at the Karolinska Institutet in Stockholm, Sweden. October 19-23, 2020 ACT Matching Events – Gender Dimension ERA Priority Groups COURSE PROGRAMME 2944: Sex & Gender Perspectives in Cardiovascular Research Doctoral Programme: DEVREG – 1.0 ECTS Karolinska Institutet (Karolina Kublickiene)
  • Azizi Z, Bender U, Tadiri C, Norris C, Raparelli V, Pilote L, for the GOINGFWD investigators. Sex and Gender Factors and the Cardiovascular Health of Canadians. Poster presentation. Canadian Cardiovascular Congress (CCC), Virtual congress, Edmonton, Alberta. October 21 to 24, 2020. (CCS/CIHR Sex- and Gender-Based Analysis (SGBA) Trainee Abstract Award).
  • Parry M, Bjørnnes AK, Clarke H, Dhukai A, Harvey P, Lalloo C, Leegaard M, Légaré F, McFetridge-Durdle J, McGillion M, Norris C, Pilote L, Price J, Stinson J, Watt-Watson J, on behalf of the at heart investigating team/study group. A mixed methods approach to develop and test a WebApp for women with heart disease. Abstract accepted to the Canadian Cardiovascular Congress (CCC) Virtual congress, Edmonton, Alberta. October 2020.
  • Bender U, Tadiri C, Raparelli V, Norris CM, Dreyer R, Pilote L, for the GOING-FWD Investigators. The Impact of Sex and Gender-related Factors on Length-of-stay Following NStemi: A Multicountry Analysis. Poster presentation. Canadian Cardiovascular Congress (CCC) Virtual congress, Edmonton, Alberta. October 21 to 24, 2020. (declined)
  • Valeria Raparelli Invited Lecture: Sex and gender as determinant of heath: towards the precision medicine era (Friday 23rd, 2020) -121 Congress of the Italian Society of Internal Medicine (23-25 October 2020)
  • Sohani Z, Behlouli H, Soares de Moura C, Abrahamowicz M, Pilote L. Is treatment with sacubitril-valsartan compared to ACE inhibitors or ARBs more beneficial for women with heart failure? Poster presentation at the Canadian Association for Population Therapeutics (CAPT) 2020 Virtual Conference. October 26 – 27, 2020.

 

November 2020

  • Bender U, Norris CM, Raparelli V, Tadiri C, Pilote L.The Impact Of Sex And Gender-related Factors On Length-of-stay Following NSTEMI: A Multicountry Analysis. Poster presentation. American Heart Association Scientific Sessions 2020 Virtual congress. November 13th to 17th, 2020.
  • Azizi Z, Gisinger T, Raparelli V, Norris CM, Kublickiene K, Herrero MT, Khaled El Emam K, Kautzky-Willer A, Pilote L. On behalf of the GOING-FWD Investigators. Sex, Gender Factors and Cardiovascular Health in Canadian and Austrian Populations. Poster presentation. American Heart Association Scientific Sessions 2020 Virtual congress. November 13th to 17th, 2020.
  • Benea D, Raparelli V, Behlouli H, Pilote L, Dryer R. The Impact of Race on In-hospital Quality of Care Among Young Adults With Acute Myocardial Infarction. Poster presentation. American Heart Association Scientific Sessions 2020 Virtual congress. November 13th to 17th, 2020.

February 2021

  1. Bender U, Raparelli V, Pilote L on behalf of the GOING-FWD Consortium. Do Sex Hormones Mediate the Effect of Gender on Acute Coronary Syndrome Outcomes? Poster presentation. 2021 Canadian Women’s Heart Health Summit. Ottawa, Ontario, Canada, February 10-13, 2021.
  2. Raparelli V, Norris CM, Herrero MT, Johnson EO, Kautzky-Willer A, Kublickiene K, Pilote L, on behalf of the GOING-FWD Consortium. The GOING-FWD (Gender Outcomes INternational Group: to Further Well-being Development) Project. Poster presentation. 2021 Canadian Women’s Heart Health Summit. Ottawa, Ontario, Canada, February 10-13, 2021.
  3. Tucci C, Tosti G, Basili S, Herrero Ezquerro MT, Johnson EO, Kautzky-Willer A, Norris CM, Pilote L, Kublickiene K, Raparelli V, on behalf of GOING FWD Consortium Gender-related Factors and Cost-sensitive Outcomes in Adults with Chronic Kidney Disease: a Systematic Review. Poster presentation. 2021 Canadian Women’s Heart Health Summit. Ottawa, Ontario, Canada, February 10-13, 2021.
  4. Tosti G, Tucci C, Basili S, Herrero Ezquerro MT, Johnson EO, Kautzky-Willer A, Norris CM, Pilote L, Kublickiene K, Raparelli V, on behalf of GOING FWD Consortium Gender-related Factors and Patient-related Outcome Measures/Patient-reported Experience Measures in Adults with Chronic Kidney Disease: a Systematic Review. Poster presentation. 2021 Canadian Women’s Heart Health Summit. Ottawa, Ontario, Canada, February 10-13, 2021.

May 2021

  1. Kaur A, Dreyer R, Marsh TW, Thanassoulis G, Raparelli V, D’Onofrio G, Engert J, Pilote L. Role of Genetics in Sex-specific Effects of Clopidogrel on Atherosthromobotic Events. Poster Presentation. ACC’s 70th Annual Scientific Session, May 15-17, 2021, in Atlanta, Georgia.
  2. Azizi Z, Pilote L, Raparelli V, Norris CM, Kublickiene K,Herrero MT, Kautzky-Willer A, El Emam K, The GOING-FWD Investigators. Sex, Gender and Cardiovascular Helath, an Analysis of Synthetic Data rom a Popluation Based Study. Poster presentation. ACC’s 70th Annual Scientific Session, May 15-17, 2021, in Atlanta, Georgia.
All Manuscripts (submitted, accepted, published) of GFWD PIs

Dec 2018 to October 2020

Dr. Louise Pilote

  • Tadiri CP, Raparelli V, Abrahamowicz M, Kautzky-Willer A, Kublickiene K, Herrero MT, Norris CM, Pilote L. Methods for prospectively incorporating gender into health sciences research. Journal of Clinical Epidemiology. Published online, Sept 23, 2020.
  • Tadiri CP, *Gisinger T, Kautzky-Willer A, Kublickiene K, Herrero MT, Raparelli V, Pilote L, Norris CM on behalf of the GOING-FWD Consortium.*indicates equally contributing co-first authors. The Influence of Sex and Gender Domains on COVID-19 Positive Cases and Mortality. CMAJ. 2020 September 8; 192(36):E1041-E1045
  • Raparelli et al.; The Eva Collaborative Group. Gender-Related Determinants of Adherence to the Mediterranean Diet in Adults with Ischemic Heart Disease. Nutrients. 2020 Mar 13;12(3). pii: E759.
  • Raparelli et al. Sex differences in effectiveness of newer glucose-lowering drugs added to metformin in type-2 diabetes. JAHA. 2020 Jan;9(1):e012940.
  • Raparelli et al. Personalized Medicine: Women in Heart Failure Clinical Trials, a Must! JACC Heart Fail. 2019 Aug;7(8):732-733.
  • Raparelli et al. EVA Collaborators. The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: insights from EVA study. Front Endocrinol (Lausanne). 2019 Feb;10:107
  • Raparelli et al. EVA Collaborators. Sex and gender differences in ischemic heart disease: Endocrine Vascular disease Approach (EVA) study design. J Cardiovasc Transl Res. 2018 Dec
  • Norris et al. Systemic incorporation of sex-specific information into clinical practice guidelines for the management of ST-segement-elevation myocardial infarction: feasibility and outcomes. J Am Heart Assoc. Apr 2019;8(7):e011597.
  • Muhammad et al. Blood pressure variability in normotensive perimenopausal women: Non-dipping status, maximum blood pressure and arterial stiffness. International Journal of Cardiology. 16 October 2020.
  • Zhao et al. High-Sensitivity (CODE-MI): Rationale and Design for a Multi-centre Stepped-Wedge Cluster Randomized Trial. American Heart Journal. 2020 November; 229:18-28.
  • Elharram et al. Anticoagulant use and the risk of thromboembolism and bleeding in post-operative AF following non-cardiac surgery. Can J Cardiol. 2020 September 4.
  • Machado et al. Real-world analyses of therapy discontinuation of checkpoint inhibitors in metastatic melanoma patients. Sci Rep. 2020 September 3; 10:14607.
  • Elharram et al. Novel glucose lowering agents are associated with a lower risk of cardiovascular and adverse events in type-2 diabetes: a population-based analysis. International Journal of Cardiology. 2020, July 1: 310, 155-156.
  • Samuel et al. Long-term effectiveness of catheter ablation in patients with atrial fibrillation and heart failure. EP Europace. euaa036, 2020 March 30.
  • Samuel et al. Population-level sex differences and predictors for treatment with catheter ablation in patients with atrial fibrillation and heart failure, CJC Open. euaa036, 2020 Jan 20
  • Parry et al. Development and usability testing of HEARTPA♀N: Protocol for a mixed methods strategy to develop an integrated smartphone and web-based intervention for women with cardiac pain. BMJ Open. 2020 March 9;10:e033092.
  • Schlosser et al. Circulating miR-206 and Wnt-signaling are associated with cardiovascular complications and a history of preeclampsia in women. Clin Sci (Lond). 2020 Jan 31;134(2):87-101.
  • Kaur A et al. Systematic Review of MicroRNA Biomarkers in Acute Coronary Syndrome and Stable Coronary Artery Disease. Cardiovasc Res. 2019 Nov 29. pii: cvz302..
  • Nattel et al. Sex as a Key Variable in Predicting Cardiovascular Outcomes: Rapidly Evolving Knowledge but Much More Needed. Can J Cardiol. 2020 Jan;36(1):1-3.
  • Samuel et al. Population‐level evaluation of complications after catheter ablation in patients with atrial fibrillation and heart failure. J Cardiovasc Electrophysiol. First published: 02 October 2019.
  • Laprise et al. Sex and Gender Considerations in Transplant Research: A Scoping Review. Transplantation. 2019 Sep;103(9):e239-e247.
  • Malhamé et al.; DYAMAN study group. Capacity Building and Innovation in Caring for Non-communicable Diseases in Maternal Global Health: The Example of Haiti. J Obstet Gynaecol Can. 2019 Oct;41(10):1479-1481.
  • Malhamé et al. Peripartum cardiomyopathy with co-incident preeclampsia: a cohort study of clinical risk factors and outcomes among commercially insured women. Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health. 2019 July;(17): 82-88.
  • McDonald et al. The MedSafer Study: A Controlled Trial of an Electronic Decision Support Tool for Deprescribing in Acute Care. J Am Geriatr Soc. 2019 Jun 27. doi: 10.1111/jgs.16040.
  • Moride et al.A systematic review of intervention and programs targeting appropriate prescribing of opioids. Pain Physician. 2019 May;22(3):229-240.
  • Danieli et al. Flexible Modeling of the Association Between Cumulative Exposure to Low-Dose Ionizing Radiation from Cardiac Procedures and the Malignancy Risk in Adults with Congenital Heart Disease. Am J Epidemiol. 2019 May 20. pii: kwz114.
  • Patel et al. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events. Circ Genom Precis Med. 2019 Apr;12(4):e002471.
  • Patel et al. Subsequent event risk in individuals with established coronary heart disease: design and rationale of the GENIUS-CHD Consortium. Circ Genom Precis Med. 2019 Apr;12(4):e002470. doi: 0.1161/CIRCGEN.119.002470.
  • Dayan et al. Impact of preeclampsia on long-term cognitive function. Hypertension. 2018 Dec;72(6):1374-80. Highest Impact Paper for Winter 2018, Clinical Science.

 

Alexandra Kautzky-Willer

Original research papers

  • Franck Mauvais-Jarvis, Heiner K. Berthold, Ilaria Campesi, Juan-Jesus Carrero, Santosh Dakal, Flavia Franconi, Ioanna Gouni-Berthold, Mark L. Heiman, Alexandra Kautzky-Willer, Sabra L. Klein, Anne Murphy, Vera Regitz-Zagrosek, Karen Reue and Joshua B. Rubin. Sex- and Gender-Based Pharmacological Response to Drugs. Pharmacological Reviews. April 2021, 73 (2) 730-762; DOI: https://doi.org/10.1124/pharmrev.120.000206

  • Harreiter et al. https://link.springer.com/article/10.1007/s11892-020-01348-2

  • Paolino et al. https://www.nature.com/articles/s41586-020-03071-0
  • Beiglböck et al. doi: 10.1210/clinem/dgaa663.
  • Deischinger et al. doi: 10.1038/s41598-020-74413-1.
  • Immanuel et al. doi: 10.1111/dme.14413.
  • Fenzl et al. doi: 10.1016/j.molmet.2020.101088.
  • Deischinger, et al. doi: 10.1136/bmjdrc-2020-001430.
  • Raber et al. doi: 10.3390/jcm9103108.
  • Kaleta M et al. doi: 10.2196/18147.
  • Dorner et al. doi: 10.1136/bmjopen-2019-035235.
  • Klepochová et al. doi: 10.1002/oby.22846.
  • Immanuel et al. doi: 10.1016/j.diabres.2020.108378.
  • Leutner et al. doi: 10.1038/s41598-020-70075-1.
  • Tura et al. doi: 10.1016/j.numecd.2020.04.004.
  • Deischinger et al. doi: 10.3390/jcm9072277.
  • Dieberger et al. doi: 10.1038/s41366-020-0639-y.
  • Lima et al. doi: 10.1111/ijpo.12628.
  • Kulterer et al. doi: 10.1210/clinem/dgaa183.
  • Harreiter et al. doi: 10.1007/s11892-020-01322-y.
  • Beiglböck et al. doi: 10.1007/s11695-020-04761-4.
  • Müller et al. doi: 10.1007/s40618-020-01309-2.
  • Beiglbock et al. doi: 10.1007/s11695-020-04698-8.
  • Wadowski et al. doi: 10.1016/j.mvr.2019.103971.
  • Lima et al. doi: 10.1111/ppe.12682.
  • Firneisz et al. doi: 10.3389/fgene.2020.00332.
  • Al-Taie et al. doi: 10.1016/j.pcd.2019.11.003.
  • Morettini et al. doi: 10.4093/dmj.2019.0016.
  • Fellinger et al. doi: 10.1172/jci.insight.134638.
  • Haug et al. doi: 10.1186/s12916-020-1508-1.
  • Riffer et al. doi: 10.1007/s00508-019-01583-y.
  • Corcoy et al. doi: 10.1016/j.clnu.2019.04.006.
  • Lehner et al. doi: 10.1111/dom.13895.
  • Breyer et al. doi: 10.1111/eci.13207.
  • Rasul et al. doi: 10.1136/bmjdrc-2019-001135.
  • Rosta et al. doi: 10.1042/BSR20194316.
  • Smajis et al. doi: 10.1093/ajcn/nqz271.
  • Bozkurt et al. doi: 10.1159/000504176.
  • Morettini et al. doi: 10.3934/mbe.2020084 .
  • Leutner et al. doi: 10.1136/annrheumdis-2019-216627.
  • Harreiter et al. doi: 10.1016/j.clnu.2018.11.035.
  • Al-Taie et al. doi: 10.1007/s00508-019-01573-0.
  • Leutner et al. doi: 10.1136/annrheumdis-2019-215714.
  • Schernthaner-Reiter et al. doi: 10.1016/j.jsxm.2019.07.009.
  • Leutner et al. doi: 10.1136/annrheumdis-2019-216494.
  • Wolf et al. doi: 10.1007/s12020-019-01974-1.
  • Harreiter et al. doi: 10.2337/dc19-0418.
  • Wolf et al. doi: 10.1530/EJE-19-0086.
  • van Poppel M et al. doi: 10.1007/s00125-019-4842-0.
  • Kainz et al. doi: 10.1093/ndt/gfy322.
  • Leutner et al. doi: 10.3389/fendo.2019.00105.
  • Morettini M et al. doi: 10.1111/eci.13099.
  • Winhofer et al. doi: 10.4158/EP-2018-0461.

Clinical recommendations/guidelines of the Austrian Diabetes Association

  • Weber T, Arbeiter K, Ardelt F, Auer J, Aufricht C, Brandt MC, Dichtl W, Ferrari J, Foger B, Henkel M, Hohenstein-Scheibenecker K, Horn S, Kautzky-Willer A, Kepplinger E, Knoflach M, Koppelstatter C, Mache C, Marschang P, Mayer G, Metzler B, Oberbauer R, Obermair F, Obermayer-Pietsch B, Perl S, Pilz S, Prischl FC, Podczeck-Schweighofer A, Rebhandl E, Rohla M, Roller-Wirnsberger R, Saely CH, Siostrzonek P, Slany J, Stoschitzky K, Waldegger S, Wenzel RR, Weiss T, Wirnsberger G, Winhofer-Stockl Y, Zweiker D, Zweiker R, Watschinger B. Österreichischer Blutdruckkonsens 2019. Wien Klin Wochenschr. 2019;131(Suppl 6):489-590. doi: 10.1007/s00508-019-01565-0.
  • Kautzky-Willer A, Harreiter J, Winhofer-Stockl Y, Bancher-Todesca D, Berger A, Repa A, Lechleitner M, Weitgasser R. Gestationsdiabetes (GDM) (Update 2019). Wien Klin Wochenschr. 2019. doi: 10.1007/s00508-018-1419-8.
  • Kautzky-Willer A, Harreiter J, Abrahamian H, Weitgasser R, Fasching P, Hoppichler F, Lechleitner M. Geschlechtsspezifische Aspekte bei Pradiabetes und Diabetes mellitus - klinische Empfehlungen (Update 2019). Wien Klin Wochenschr. 2019. doi: 10.1007/s00508-018-1421-1.
  • Sourij H, Edlinger R, Prischl FC, Auinger M, Kaser S, Horn S, Paulweber B, Kautzky-Willer A, Saemann M, Prager R, Clodi M, Schernthaner G, Mayer G, Oberbauer R, Rosenkranz AR. Diabetische Nierenerkrankung (Update 2019) : Positionspapier der Österreichischen Diabetes Gesellschaft und der Österreichischen Gesellschaft fur Nephrologie. Wien Klin Wochenschr. 2019. doi: 10.1007/s00508-018-1425-x.
  • Kautzky-Willer A, Harreiter J, Winhofer-Stockl Y, Weitgasser R, Lechleitner M. Graviditat bei vorbestehendem Diabetes (Update 2019). Wien Klin Wochenschr. 2019. doi: 10.1007/s00508-019-1456-y.
  • Abrahamian H, Kautzky-Willer A, Riessland-Seifert A, Fasching P, Ebenbichler C, Kautzky A, Hofmann P, Toplak H. Psychische Erkrankungen und Diabetes mellitus (Update 2019). Wien Klin Wochenschr. 2019. doi: 10.1007/s00508-019-1458-9.
  • Muschitz C, Kautzky-Willer A, Rauner M, Winhofer-Stockl Y, Haschka J. Diagnose und Management der Osteoporose bei Diabetes mellitus (Update 2019) : Gemeinsame Leitlinie der Österreichischen Gesellschaft fur Knochen- und Mineralstoffwechsel und der Österreichischen Diabetes Gesellschaft. Wien Klin Wochenschr. 2019. doi: 10.1007/s00508-019-1462-0.
  • Schindler K, Brix J, Damon S, Hoppichler F, Kautzky-Willer A, Kruschitz R, Toplak H, Ludvik B. Ernährungsempfehlungen bei Diabetes mellitus (Update 2019). Wien Klin Wochenschr. 2019. doi: 10.1007/s00508-019-1470-0.
  • Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, Foger B, Francesconi C, Frohlich-Reiterer E, Harreiter J, Hofer SE, Hoppichler F, Huber J, Kaser S, Kautzky-Willer A, Lechleitner M, Ludvik B, Luger A, Mader JK, Paulweber B, Pieber T, Prager R, Rami-Merhar B, Resl M, Riedl M, Roden M, Saely CH, Schelkshorn C, Schernthaner G, Sourij H, Stechemesser L, Stingl H, Toplak H, Wascher TC, Weitgasser R, Winhofer-Stockl Y, Zlamal-Fortunat S. Antihyperglykamische Therapie bei Diabetes mellitus Typ 2 (Update 2019). Wien Klin Wochenschr. 2019. doi: 10.1007/s00508-019-1471-z.
  • Winhofer-Stockl Y, Clodi M, Kautzky-Willer A. Zusammenfassung der Überarbeitungen 2019. Wien Klin Wochenschr. 2019. doi: 10.1007/s00508-019-1482-9.
  • Schütz-Fuhrmann I, Stadler M, Zlamal-Fortunat S, Rami-Merhar B, Fröhlich-Reiterer E, Hofer SE, Mader J, Resl M, Bischof M, Kautzky-Willer A, Weitgasser R. Insulinpumpentherapie bei Kindern, Jugendlichen und Erwachsenen (Update 2019). Wien Klin Wochenschr. 2019. doi: 10.1007/s00508-019-1485-6.
  • Lechleitner M, Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, Foger B, Francesconi C, Frohlich-Reiterer E, Harreiter J, Hofer SE, Hoppichler F, Huber J, Kaser S, Kautzky-Willer A, Ludvik B, Luger A, Mader JK, Paulweber B, Pieber T, Prager R, Rami-Merhar B, Resl M, Riedl M, Roden M, Saely CH, Schelkshorn C, Schernthaner G, Sourij H, Stechemesser L, Stingl H, Toplak H, Wascher TC, Weitgasser R, Winhofer-Stockl Y, Zlamal-Fortunat S. Insulintherapie bei Typ 2 Diabetes mellitus (Update 2019). Wien Klin Wochenschr. 2019. doi: 10.1007/s00508-019-1492-7.
  • Lechleitner M, Kaser S, Hoppichler F, Roden M, Weitgasser R, Ludvik B, Fasching P, Winhofer-Stockl Y, Kautzky-Willer A, Schernthaner G, Prager R, Wascher TC, Clodi M. Diagnostik und Therapie des Typ 1 Diabetes mellitus (Update 2019). Wien Klin Wochenschr. 2019. doi: 10.1007/s00508-019-1493-6.

Reviews

  • Harreiter J, Fadl H, Kautzky-Willer A, Simmons D. Do Women with Diabetes Need More Intensive Action for Cardiovascular Reduction than Men with Diabetes? Curr Diab Rep. 2020;20(11):61. doi: 10.1007/s11892-020-01348-2.
  • Consoli A, Czupryniak L, Duarte R, Jermendy G, Kautzky-Willer A, Mathieu C, Melo M, Mosenzon O, Nobels F, Papanas N, Roman G, Schnell O, Sotiropoulos A, Stehouwer CDA, Tack CJ, Woo V, Fadini GP, Raz I. Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel. Diabetes Obes Metab. 2020. doi: 10.1111/dom.14102.
  • Farkouh A, Riedl T, Gottardi R, Czejka M, Kautzky-Willer A. Sex-Related Differences in Pharmacokinetics and Pharmacodynamics of Frequently Prescribed Drugs: A Review of the Literature. Adv Ther. 2020;37(2):644-55. doi: 10.1007/s12325-019-01201-3.
  • Harreiter J, Desoye G, van Poppel MNM, Kautzky-Willer A, Dunne F, Corcoy R, Devlieger R, Simmons D, Adelantado JM, Damm P, Mathiesen ER, Jensen DM, Anderson LLT, Lapolla A, Dalfra MG, Bertolotto A, Wender-Ozegowska E, Zawiejska A, Hill DJ, Snoek FJ. The Effects of Lifestyle and/or Vitamin D Supplementation Interventions on Pregnancy Outcomes: What Have We Learned from the DALI Studies? Curr Diab Rep. 2019;19(12):162. doi: 10.1007/s11892-019-1282-7.

Editorials

  • Kautzky-Willer A, von Euler M, Oertelt-Prigione S. Editorial: Sex and Gender Aspects in Diabetes. Front Endocrinol (Lausanne). 2019;10:813. doi: 10.3389/fendo.2019.00813.

Book Chapters

  • Stupin JH, Hüseman D, Kraus B, Eberle C, Harreiter J, Kautzky-Willer A, Klapp C, Arabin B. Postpartale Therapie und Langzeitprognose In: Stupin JH, Schäfer-Graf U, Hummel M, editors. Diabetes in der Schwangerschaft. Berlin/Boston: De Gruyter; 2020. p. 201-300, doi: 10.1515/9783110569186-006.
  • Kautzky-Willer A, Hösli I, Huhn EA. Länderspezifische Besonderheiten im deutschsprachigen Raum In: Stupin JH, Schäfer-Graf U, Hummel M, editors. Diabetes in der Schwangerschaft. Berlin/Boston: De Gruyter; 2020. p. 337-44, doi: 10.1515/9783110569186-010.

 

Karolina Kublickiene

  • Barrett et al. Action needed for long-term benefit. Acta Obstet Gynecol Scand. 2020 Sep;99(9):1107-1109.
  • Barrett et al. Hypertensive disorders of pregnancy and the risk of chronic kidney disease: A Swedish registry-based cohort study. PLoS Med. 2020 Aug 14;17(8):e1003255.
  • Ebert T et al. Inflammation and Premature Ageing in Chronic Kidney Disease. Toxins (Basel). 2020 Apr 4;12(4):227.
  • Barrett et al. Risk of long-term renal disease in women with ahistory of preterm delivery: a population-based cohort study. BMC Med. 2020 Apr 1;18(1):66.
  • Barrett et al. Stillbirth is associated with increased risk of long- term maternal renal disease: a nationwide cohort study. Am J Obstet Gynecol. 2020 Sep;223(3):427.e1-427.e14.
  • Arefin et al. Nrf2 in early vascular ageing: Calcification, senescence and therapy. Clin Chim Acta. 2020 Jun;505:108-118.
  • Barrett et al. Adverse Pregnancy Outcomes and Long-term Maternal Kidney Disease: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020 Feb 5;3(2):e1920964..
  • Khashan et al. Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study. PLoS Med. 2019 Jul 30;16(7):e1002875. doi: 10.1371/journal.pmed.1002875. Erratum in: PLoS Med. 2019 Oct 24;16(10):e1002977.
In press and submitted Manuscripts
  • Thomas Ebert1,*, Johanna Painer2,*, Peter Bergman3, Abdul Rashid Qureshi1, Sylvain Giroud2, Gabrielle Stalder2, Karolina Kublickiene1, Sebastian Vetter2, Frank Göritz4, Ole Fröbert5, Jon M. Arnemo6,7, Andreas Zedrosser8, Irene Redtenbacher9, Paul G. Shiels10, Richard J. Johnson11, Peter Stenvinkel1 The effect of diet, hibernation and chronic kidney disease on betaine, choline, and TMAO – a comparative biomimetic approach, in press 2020; scientific reports
  • Thomas Ebert1#*, Ognian Neytchev2#, Anna Witasp1, Karolina Kublickiene1, Peter Stenvinkel1#, Paul G. Shiels2# FORUM REVIEW ARTICLE Inflammation and oxidative stress in CKD and dialysis patients, in press 2020 at in Antioxidants & Redox Signaling.
  • Peter M. Barrett, Fergus P. McCarthy, Marie Evans, Marius Kublickas , Ivan J. Perry, Peter Stenvinkel , Karolina Kublickiene*, Ali S. Khashan*. Gestational diabetes and the long-term risk of maternal kidney disease: a Swedish national cohort study, submitted.
  • Takahiko Nakagawa1,2, Ana Andres-Hernando3, Tomoki Kosugi4, Laura G Sanchez-Lozada5, Peter Stenvinkel6, Karolina Kublickiene6, S Ananth Karumanchi7, Duk-Hee Kang8, Hideto Kojima2, Bernardo Rodriguez-Iturbe9, Dean R Tolan10, Miguel A. Lanaspa3*, Richard J. Johnson3 Fructose: A Clue to the Origin of Preeclampsia? Insights from Nature and Evolution, resubmitted
  • Brain and Gut Axis in Chronic Kidney Disease: Focus on Specific Biomarkers, Tight Junction Proteins and Sex differences” by Leah Hernandez, Liam Ward, Samsul Arefin, Agne Laucyte-Cibulskiene Thomas Ebert, Peter Stenvinkel and Karolina Kublickiene, Submitted.
  • SARS-CoV-2 receptor ACE-2, TMPRSS2 and soluble ACE-2 in male and females patients with Chronic Kidney Disease by by Leah Hernandez, Samsul Arefin, Liam Ward, Peter Stenvinkel and Karolina Kublickiene; Submitted.
  • Resistance Vasculature in Chronic Kidney Disease: focus on function, structure, senescence signature and sex differences by Samsul Arefin1; Neja Mudrovcic1; Sam Hobson1Thomas Ebert1; Liam Ward; Anna Witasp1, Julia Steinmetz-Späh2; Karin Larsson2; Peter Stenvinkel1; Karolina Kublickiene1*, submitted.
  • Cardioprotective effects of mPGES-1 inhibition in human resistance sized arteries from male and female patients with chronic inflammation by Julia Steinmetz-Späh, Samsul Arefin, Karin Larsson, Jabin Jahan, Peter Stenvinkel, Marina Korotkova, Karolina Kublickiene*, Per-Johan Jakobsson*, under preparation.

Funded Grant

  • Ongoing eu grant for ACT on gender ending 2021 due to extension. Kidney foundation 2019, and 2020 funded PI. CIMED co-applicant funded2020-2023. Heart-Lung foundation-Co PI funded 2019-2020. SRC funded Co PI funded 2019-3 years.
  • 952516 — ERIN — H2020-WIDESPREAD-2018-2020 / H2020-WIDESPREAD-2020-5 Ethically Responsible Innovations in Reproductive Medicine.

 

Maria Trinidad Herrero

  • Cardiac noradrenaline turnover and heat shock protein 27 phosphorylation in dyskinetic monkeys. Almela P, Cuenca-Bermejo L, Yuste JE, Estrada C, de Pablos V, Bautista-Hernández V, Fernandez-Villalba E, Laorden ML, Herrero MT. Mov Disorders 2019 Dec 24. doi: 10.1002/mds.27958 (in press).
  • Voluntary exercise reduces plasma cortisol levels and improves transitory memory impairment in young and aged Octodon degus. Estrada C, Cuenca L, Cano-Fernandez L, Gil-Martinez AL, Sanchez-Rodrigo C, González-Cuello AM, Fernandez-Villalba E, Herrero MT. Behav Brain Res. 2019 Nov 5;373:112066. doi: 10.1016/j.bbr.2019.112066.
  • A role for DJ-1 against oxidative stress in the mammalian retina. Martín-Nieto J, Uribe ML, Esteve-Rudd J, Herrero MT, Campello L. Neurosci Lett. 2019 Aug 24;708:134361. doi: 10.1016/j.neulet.2019.134361.
  • Local Gastrointestinal Injury Exacerbates Inflammation and Dopaminergic Cell Death in Parkinsonian Mice. Gil-Martínez AL, Estrada C, Cuenca L, Cano JA, Valiente M, Martez-Cáceres C, Fernández-Villalba E, Herrero MT. Neurotox Res. 2019 May;35(4):918-930. doi: 10.1007/s12640-019-0010-z.
  • Parkinson's disease: a short story of 200 years. Cuenca L, Gil-Martinez AL, Cano-Fernandez L, Sanchez-Rodrigo C, Estrada C, Fernandez-Villalba E, Herrero MT. Histol Histopathol. 2019 Jun;34(6):573-591. doi: 10.14670/HH-18-073.
  • Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential? Gil-Martínez AL, Cuenca L, Sánchez C, Estrada C, Fernández-Villalba E, Herrero MT.

 

Projects/Initiatives related to current COVID-19 pandemic - September 2020

GOING-FWD Consortium

Publications

  • Tadiri CP, Gisinger T, Kautzky-Willer A, Kublickiene K, Herrero MT, Raparelli V, Pilote L, Norris CM; GOING-FWD Consortium. The influence of sex and gender domains on COVID-19 cases and mortality. CMAJ. 2020 Sep 8;192(36):E1041-E1045. doi: 10.1503/cmaj.200971. PMID: 32900766. (https://www.cmaj.ca/content/192/36/E1041).
  • Letter to Editors of Medical Journals at the beginning of the pandemic: Urgent Need of Sex and Gender-Informed Approach in Reporting Data on COVID-19 Pandemic.

Social media

Ongoing studies

  • GOING-FWD and iCARE (International assessment of COVID-19-related attitudes, concerns, responses and impacts in relation to public health policies) Study: survey aimed at understanding people’s awareness, attitudes, beliefs, and behaviours about COVID-19, proposed by a group of over 150 researchers from more than 40 countries – https://mbmc-cmcm.ca/covid19/
  • The project is led by Dr Simon Bacon (team member of the GOING-FWD Consortium) and Dr Kim Lavoie. As part of the GOING-FWD activity, analysis plan proposal on testing the effect of sex and gender on public perceptions and behavioral responses to COVID-19 outbreak in a global multicountries perspective (Sex - and gender-related determinants of public perceptions and behavioral responses to the COVID-19 outbreak: a multi-countries comparison study)

 

Louise Pilote

Presentation

Ongoing studies

  • UK Biobank analysis: Assessing risk factors of contracting COVID-19 infection in confirmed COVID-19 patients vs control: a Prospective population-based cohort
  • The Impact of Sex and Gender on Health Care Workers During the COVID-19 Pandemic. (Louise Pilote and Colleen Norris are both part of a research group with Dr. Sofia Ahmed in Alberta, to survey Health Care workers across Canada)

 

Colleen Norris

Presentation

  • Heart and Stroke Foundation of Canada Webinar on April 21, 2020: Sex and gender differences and COVID-19.

https://www.youtube.com/watch?time_continue=1&v=yn_R9Y1Y2CU&feature=emb_logo

 

Valeria Raparelli

  • Raparelli et al.; The Eva Collaborative Group. Gender-Related Determinants of Adherence to the Mediterranean Diet in Adults with Ischemic Heart Disease. Nutrients. 2020 Mar 13;12(3). pii: E759.
  • Raparelli et al. Sex differences in effectiveness of newer glucose-lowering drugs added to metformin in type-2 diabetes. JAHA. 2020 Jan;9(1):e012940.
  • Raparelli et al. Personalized Medicine: Women in Heart Failure Clinical Trials, a Must! JACC Heart Fail. 2019 Aug;7(8):732-733.
  • Raparelli et al. EVA Collaborators. The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: insights from EVA study. Front Endocrinol (Lausanne). 2019 Feb;10:107
  • Raparelli et al. EVA Collaborators. Sex and gender differences in ischemic heart disease: Endocrine Vascular disease Approach (EVA) study design. J Cardiovasc Transl Res. 2018 Dec

Member of the Italian National Institute of Health (Instituto Superiore di Sanita, ISS) SARS-CoV-2 Surveillance Group (COVID-19 Mortality Group): "Investigation of Covid-19 related biomedical data or participation to activities (surveys, working groups etc.) exploring its socio-economical or cultural context"

 

Publications

Publication related to sex and gender-based research

  • Raparelli V, Palmieri L, Canevelli M, Pricci F, Brigid Unim B, Lo Noce C, Villani ER, Rochon PA, Pilote L, Vanacore N, Onder G. Sex Differences in Clinical Phenotype and Transitions of Care among Individuals Dying of COVID-19 in Italy. Biol Sex Differ. 2020 Oct 16;11(1):57. doi: 10.1186/s13293-020-00334-3. PMID: 33066823; PMCID: PMC7562690
  • Canevelli M, Palmieri L, Raparelli V, Punzo O, Donfrancesco C, Lo Noce C, Vanacore N, Brusaferro S, Onder G; Italian National Institute of Health COVID-19 Mortality Group. COVID-19 mortality among migrants living in Italy. Ann Ist Super Sanita. 2020 Jul-Sep;56(3):373-377. doi: 10.4415/ANN_20_03_16. PMID: 32959804.

 

Other COVID-19 Related publications from ISS COVID-19 Mortality Group

  • Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683. Erratum in: JAMA. 2020 Apr 28;323(16):1619. PMID: 32203977. (Raparelli V listed as Additional Contributions) (https://jamanetwork.com/journals/jama/fullarticle/2763667)
  • Onder G, Palmieri L, Vanacore N, Giuliano M, Brusaferro S; Italian National Institute of Health COVID-19 mortality group (Raparelli V). Non-respiratory Complications and Obesity in Patients Dying with COVID-19 in Italy. Obesity (Silver Spring). 2020 Aug 18. doi: 10.1002/oby.23007. Epub ahead of print. PMID: 32812383. (https://onlinelibrary.wiley.com/doi/abs/10.1002/oby.23007)
  • Palmieri L, Vanacore N, Donfrancesco C, Lo Noce C, Canevelli M, Punzo O, Raparelli V, Pezzotti P, Riccardo F, Bella A, Fabiani M, D'Ancona FP, Vaianella L, Tiple D, Colaizzo E, Palmer K, Rezza G, Piccioli A, Brusaferro S, Onder G; Italian National Institute of Health COVID-19 Mortality Group. Clinical Characteristics of Hospitalized Individuals Dying With COVID-19 by Age Group in Italy. J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1796-1800. doi: 10.1093/gerona/glaa146. PMID: 32506122; PMCID: PMC7314182.(https://academic.oup.com/biomedgerontology/article/75/9/1796/5854361)
  • Canevelli M., Palmieri L, Raparelli V, Lo Noce C, Colaizzo E, Tiple D, Vaianella L, Vanacore N, Brusaferro S, Onder G, and the Italian National Institute of Health COVID-19 Mortality Group. Prevalence and clinical correlates of dementia among COVID-19-related deaths in Italy. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2020 - Accepted for publication (Original article)
  • Canevelli M, Remoli G, Trentin F, Riccardi G, Tariciotti L, Risoleo G, Bruno G, Cesari M, Vanacore N, Raparelli V. The pipeline of therapeutics testing during the emergency phase of the COVID-19 outbreak. Front. Med. 2020 doi: 10.3389/fmed.2020.552991 (Systematic Review) (https://www.frontiersin.org/articles/10.3389/fmed.2020.552991/full)
  • Romiti GF, Corica B, Cangemi R, Basili S, Raparelli V. Need for innovative and timely synthesis of evidence during Covid-19 outbreak. Eur J Intern Med. 2020 Jul;77:165-166. doi: 10.1016/j.ejim.2020.06.007. Epub 2020 Jun 7. PMID: 32532662; PMCID: PMC7275984. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275984/)

 

Ongoing studies

  • Italian Team Collaborator of the iCARE (International assessment of COVID-19-related attitudes, concerns, responses and impacts in relation to public health policies) Study
  • Title of the Project "Public perceptions and behavioural responses to the COVID-19 emergency in Italy: Results from the iCARE study" Project led by Dr Jovana Stojanovic (co-investigators: Kim Lavoie, PhD (University du Québec à Montréal (UQAM), Canada); Simon Bacon, PhD (Concordia University, Canada); Paula AB Ribeiro, PhD (Montreal Behavioural Medicine Centre, Canada); Valeria Raparelli, PhD (Sapienza – University of Rome, Italy); Stefania Boccia, PhD (Università Cattolica del Sacro Cuore, Italy) https://mbmc-cmcm.ca/covid19/apl/log/

 

Karolina Kublickiene

Ongoing studies

  • SARS-CoV-2 receptor ACE-2, TMPRSS2 and soluble ACE2 in patients with chronic kidney disease: focus on sex differences and treatment with ACE inhibitors or AR blockers.
  • Vascular structure and function in patients with CKD and after Covid19 episode: Focus on exaggerated vascular senescence.
  • Maintenance and update with relevant information for https://www.mcgill.ca/going-fwd4gender/covid19
  • Maintenance and update with relevant information and participations for matching events with focus on COVID 19 at project and consortium -https://www.act-on-gender.eu

 

Maria Trinidad Herrero Ezquerro

Ongoing studies

  • Title: Thromboembolism (TE) as a consequence to COVID-19 infection. Are gender, social factors and different treatments related to these sequelae? What about contraceptive pill?
  • Objective 1: Analyze the relation of social factors (cultural, economic and demographic) and different treatments in the pulmonary embolism (PE) as sequel caused by COVID-19 infection in the population which has suffered the disease, with a gender perspective.
  • Objective 2: Analyze the relation of social factors (cultural, economic and demographic) and different treatments in the deep veins thrombosis (DVT) as sequelae caused by COVID-19 infection in the population which has suffered the disease, with a gender perspective.

 

Alexandra Kautzky-Willer

Ongoing studies

  • Projects are restricted to Austrian data: outcomes in patients with diabetes
  • Collaboration in regard to resilience of health care systems in the pandemic

Future studies:

  • We would like to do some sex/gender analysis in the iCARE study on the German countries

 

Ruth Sapir-Pichhadze

Assistant Professor of Medicine Division of Nephrology and Multi-Organ Transplant Program Department of Medicine, McGill University Royal Victoria Hospital- Glen

Presentation:

 

Monica Parry

Ongoing studies

  • Family Carers and COVID-19: A Rapid Integrated Mixed Methods Systematic Review (Louise Pilote - GOING-FWD PI, Colleen Norris - GOING-FWD CO-PI, Kyle Warkentin and Nicole Nickerson – both Patient Partners from GOING-FWD are Co-Investigators on this CIHR funded grant)
  • Unpaid Caregivers and COVID-19: An explanatory sequential mixed methods study (Louise Pilote - GOING-FWD PI, Colleen Norris - GOING-FWD CO-PI, Kyle Warkentin and Nicole Nickerson – both Patient Partners from GOING-FWD are are Co-Applicants on this grant ill be submitted to CIHR.

Publications

  • Parry M, Bjørnnes AK, Peter E, Nickerson N, Warkentin K, Pilote L, Norris C, Burnside H, Hemani S, Nylen-Eriksen M, Mohammed S, O’Hara A, & Coupal A. Unpaid Caregiver’s Mental Health and Wellbeing during Communicable Coronavirus Outbreaks: A Scoping Review (will be submitted to BMJ)

 

Simon Bacon

Ongoing studies

  • Lead PI of the iCARE Study (International assessment of COVID-19-related attitudes, concerns, responses and impacts in relation to public health policies)
Back to top